CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

for the period ended 31 March 2020

  Download (EXCEL)

 

 

  Stated
capital
and
reserves
R’m
Non-
controlling
interest
R’m
Total
equity
R’m
 
Balance at 1 October 20191  16 188  1 303  17 491    
Total comprehensive income for the period  2 818  182  3 000    
   Profit for the period  781  155  936    
   Other comprehensive profit  2 037  27  2 064    
Transactions with non-controlling interests  (58) (24) (82)   
Purchase of treasury shares  (3) –  (3)   
Distributions to shareholders  (778) (144) (922)   
Share-based payment charge for staff benefit schemes  41  –  41    
Balance at 31 March 2020  18 208  1 317  19 525    
Balance at 1 October 2018 (as previously reported) 14 916  1 286  16 202    
Transition adjustment relating to IFRS 9  20  –  20    
Balance at 1 October 2018 (restated) 14 936  1 286  16 222    
Total comprehensive income for the period  812  148  960    
   Profit for the period  357  141  498    
   Other comprehensive income  455  462    
Transactions with non-controlling interests  (35) (7) (42)   
Distributions to shareholders  (734) (150) (884)   
Share-based payment charge for staff benefit schemes  43  –  43    
Balance at 31 March 2019  15 022  1 277  16 299    
1 There was no net impact on retained earnings on 1 October 2019 as a result of adopting IFRS 16.

Connect with us


© Copyright by Life Healthcare group. All rights reserved.